Prospective Evaluation of the Proceed Ventral Patch With and Without Laparoscopic Evaluation
- Conditions
- Ventral HerniasUmbilical Hernias
- Interventions
- Device: Proceed Ventral Patch placement
- Registration Number
- NCT01183325
- Lead Sponsor
- University Hospital, Ghent
- Brief Summary
For small (2-3cm) ventral and umbilical hernias the discussion for primary suture repair or the use of mesh continues.
About 5 years ago the Ventralex patch was introduced, which combines a layer of PTFE mesh with a small polypropylene mesh and includes a circular memory ring. Despite the elegance of using this patch, recent experience showed several drawbacks both in design and efficacy (3).
With the recent development of the Proceed Ventral Patch (PVP), new elements have been introduced to overcome some of these issues.
The aim of this study is to evaluate the efficacy of clinical placement of the PVP in the intra-abdominal position in the treatment of small ventral hernias.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 160
- Adult patient
- Written informed consent
- Umbilical, primary ventral hernias smaller than 3cm diameter
- Hernias larger than 3cm
- Recurrence
- Children
- Emergency cases
- Incisional hernias
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Proceed Ventral Patch placement Proceed Ventral Patch placement Placement of a Proceed Ventral Patch for umbilical and small ventral hernias less than 3cm diameter with and without laparoscopic control
- Primary Outcome Measures
Name Time Method Percentage of adequately placed patches At T 0 days
- Secondary Outcome Measures
Name Time Method Reasons for inadequate positioning At T 0 days Perioperative morbidity rate Within 30 days Number of patients needed a repositioning of the patch At T 0 days Number of repositioning necessary At T 0 days Complication ratio At 1 year Pre- and postoperative pain At T 0 day, T 30 days and T 1 year Recurrence rate at 1 year At 1 year
Trial Locations
- Locations (2)
Imelda Hospital
🇧🇪Bonheiden, Belgium
University Hospital Ghent
🇧🇪Ghent, Belgium